Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LSEA
2501
DELISTED
Landsea Homes
LSEA
| $1.03M | ﹤0.01% |
111,899
+37,633
| +51% | +$400K |
|
2502
Interparfums
IPAR
$3.81B
| $1.02M | ﹤0.01% |
8,827
-9,248
| -51% | -$1.12M |
|
2503
PUT
Sociedad Química y Minera de Chile
SQM
$20.7B
| $1.02M | ﹤0.01% |
25,000
-51,600
| -67% | -$2.38M |
|
2504
CALL
Children's Place
PLCE
$58.9M
| $1.02M | ﹤0.01% |
125,000
-90
| -0.1% | -$854 |
|
2505
CALL
Intellia Therapeutics
NTLA
$1.57B
| $1.02M | ﹤0.01% |
45,400
-29,100
| -39% | -$693K |
|
|
AVDX
2506
DELISTED
AvidXchange
AVDX
| $1.01M | ﹤0.01% |
84,089
-54,017
| -39% | -$617K |
|
2507
CALL
NatWest
NWG
$75.8B
| $1.01M | ﹤0.01% |
+125,800
| New | +$977K |
|
2508
TriCo Bancshares
TCBK
$1.84B
| $1.01M | ﹤0.01% |
25,500
-16,120
| -39% | -$583K |
|
2509
Washington Trust Bancorp
WASH
$745M
| $1.01M | ﹤0.01% |
36,804
-12,292
| -25% | -$319K |
|
2510
Sylvamo
SLVM
$1.5B
| $1.01M | ﹤0.01% |
14,705
-25,436
| -63% | -$1.68M |
|
2511
Iris Energy
IREN
$13.6B
| $1.01M | ﹤0.01% |
+89,120
| New | +$668K |
|
2512
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
| $1.01M | ﹤0.01% |
15,490
+240
| +2% | +$15.5K |
|
2513
ImmunityBio
IBRX
$7.76B
| $1M | ﹤0.01% |
158,788
-226,881
| -59% | -$1.5M |
|
2514
ProPetro Holding
PUMP
$1.34B
| $1M | ﹤0.01% |
115,711
-55,846
| -33% | -$498K |
|
2515
Kemper
KMPR
$1.76B
| $1M | ﹤0.01% |
16,871
-42,978
| -72% | -$2.52M |
|
2516
4D Molecular Therapeutics
FDMT
$552M
| $1M | ﹤0.01% |
47,646
-173
| -0.4% | -$4.34K |
|
2517
Vanguard International Dividend Appreciation ETF
VIGI
$9.19B
| $997K | ﹤0.01% |
12,270
-60
| -0.5% | -$4.82K |
|
2518
Dana Inc
DAN
$2.94B
| $995K | ﹤0.01% |
82,125
-79,348
| -49% | -$1.03M |
|
|
SQSP
2519
DELISTED
Squarespace, Inc.
SQSP
| $995K | ﹤0.01% |
22,811
-563,536
| -96% | -$22.6M |
|
2520
Helix Energy Solutions
HLX
$1.45B
| $992K | ﹤0.01% |
83,050
-82,060
| -50% | -$915K |
|
2521
Manitowoc
MTW
$510M
| $988K | ﹤0.01% |
85,667
-19,014
| -18% | -$235K |
|
2522
Winmark
WINA
$1.27B
| $983K | ﹤0.01% |
2,789
-1,232
| -31% | -$440K |
|
2523
Oceaneering
OII
$4.9B
| $983K | ﹤0.01% |
41,539
-49,024
| -54% | -$1.13M |
|
|
CERE
2524
CALL
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $981K | ﹤0.01% |
+24,000
| New | +$999K |
|
2525
Dillards
DDS
$9.64B
| $979K | ﹤0.01% |
2,224
-2,487
| -53% | -$1.08M |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.